In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...

Becton Dickinson & Co. closed 10.30% short of its 52-week high of $251.99, which the company reached on February 3rd.

Becton Dickinson (BDX) explores divesting its $21B life sciences unit, engaging with rivals like Thermo Fisher (TMO) & ...

The Financial Times reports today that BD (NYSE: BDX) began discussions with competitors for the sale of its Life Sciences ...

To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment ...

BD Life Sciences-Biosciences held a two-day workshop at Christian Medical College, Vellore, focusing on advanced technologies ...

U.S. medical device maker Becton Dickinson is in talks with Thermo Fisher and Danaher for a potential sale of its life sciences unit, the Financial Times reported on Tuesday. Becton Dickinson had in ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

In a clip premiering exclusively with PEOPLE from the Monday, March 31 episode of The Voice, BD.ii and Kolby Cordell put on ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...